These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

306 related items for PubMed ID: 17576697

  • 1. Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.
    Parkins MD, Sabuda DM, Elsayed S, Laupland KB.
    J Antimicrob Chemother; 2007 Sep; 60(3):613-8. PubMed ID: 17576697
    [Abstract] [Full Text] [Related]

  • 2. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O, AmarCand Study Group.
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
    Garey KW, Rege M, Pai MP, Mingo DE, Suda KJ, Turpin RS, Bearden DT.
    Clin Infect Dis; 2006 Jul 01; 43(1):25-31. PubMed ID: 16758414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Invasive Candida species infections: a 5 year population-based assessment.
    Laupland KB, Gregson DB, Church DL, Ross T, Elsayed S.
    J Antimicrob Chemother; 2005 Sep 01; 56(3):532-7. PubMed ID: 16040623
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Candida spp. bloodstream infection: influence of antifungal treatment on outcome.
    Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Pitart C, Mensa J.
    J Antimicrob Chemother; 2010 Mar 01; 65(3):562-8. PubMed ID: 20083551
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Potential risk factors for infection with Candida spp. in critically ill patients.
    Peres-Bota D, Rodriguez-Villalobos H, Dimopoulos G, Melot C, Vincent JL.
    Clin Microbiol Infect; 2004 Jun 01; 10(6):550-5. PubMed ID: 15191384
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
    Tumbarello M, Sanguinetti M, Trecarichi EM, La Sorda M, Rossi M, de Carolis E, de Gaetano Donati K, Fadda G, Cauda R, Posteraro B.
    J Antimicrob Chemother; 2008 Dec 01; 62(6):1379-85. PubMed ID: 18782778
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.